FDA turns down ViiV Healthcare’s injectable HIV drug – MedCity News

In an announcement over the weekend, the British drugmaker said the FDA had cited manufacturing issues in its complete response letter for cabotegravir and rilpivirine.

Read the full article here

Related Articles